WallStreetZenWallStreetZen

NASDAQ: PBAX
Phoenix Biotech Acquisition Corp Stock

$10.70+0.00 (+0%)
Updated Mar 17, 2023
PBAX Price
$10.70
Fair Value Price
N/A
Market Cap
$245.90M
52 Week Low
$9.97
52 Week High
$10.70
P/E
N/A
P/B
-27.15x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.11
Operating Cash Flow
N/A
Beta
-0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PBAX Overview

Phoenix Biotech Acquisition Corp. is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the healthcare and healthcare-related sectors in the U.S. and Europe. Phoenix Biotech Acquisition was incorporated in 2021 and is headquartered in Oakland, CA.

Zen Score

Industry Average (6)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PBAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PBAX's short-term liabilities ($875.97k) exceed its short-term assets ($785.29k)
Short-term Liabilities Financials
PBAX's long-term liabilities ($9.15M) exceed its short-term assets ($785.29k)
Long-term Liabilities Financials
PBAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more PBAX due diligence checks available for Premium users.

Be the first to know about important PBAX news, forecast changes, insider trades & much more!

PBAX News

Valuation

PBAX fair value

Fair Value of PBAX stock based on Discounted Cash Flow (DCF)
Price
$10.70
Fair Value
$10.27
Overvalued by
4.17%

PBAX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0x
Industry
17.79x
Market
21.81x

PBAX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-27.15x
Industry
-38.44x

PBAX's financial health

Profit margin

Revenue
$0.0
Net Income
$84.5k
Profit Margin
0%

Assets to liabilities

Assets
$180.5M
Liabilities
$10.0M
Debt to equity
-1.11
PBAX's short-term liabilities ($875.97k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PBAX's long-term liabilities ($9.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PBAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PBAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$174.3k
Investing
$0.0
Financing
$0.0

PBAX vs Shell Company Stocks

TickerMarket Cap1d %P/EP/B
PBAX$245.90M0.00%N/A-27.15x
CSLM$245.01M+0.15%-7.71x-39.06x
NHIC$247.28M-0.05%N/A-47.66x
BYNO$247.78M0.00%-517.50x-48.28x
NVAC$249.90M-0.89%34.47x-403.41x

Phoenix Biotech Acquisition Stock FAQ

What is Phoenix Biotech Acquisition's quote symbol?

NASDAQ: PBAX) Phoenix Biotech Acquisition trades on the NASDAQ under the ticker symbol PBAX. Phoenix Biotech Acquisition stock quotes can also be displayed as NASDAQ: PBAX.

If you're new to stock investing, here's how to buy Phoenix Biotech Acquisition stock.

What is the 52 week high and low for Phoenix Biotech Acquisition (NASDAQ: PBAX)?

(NASDAQ: PBAX) Phoenix Biotech Acquisition's 52-week high was $10.70, and its 52-week low was $9.97. It is currently at its 52-week high and 7.32% from its 52-week low.

How much is Phoenix Biotech Acquisition stock worth today?

(NASDAQ: PBAX) Phoenix Biotech Acquisition currently has 22,981,250 outstanding shares. With Phoenix Biotech Acquisition stock trading at $10.70 per share, the total value of Phoenix Biotech Acquisition stock (market capitalization) is $245.90M.

Phoenix Biotech Acquisition stock was originally listed at a price of $10.08 in Oct 6, 2021. If you had invested in Phoenix Biotech Acquisition stock at $10.08, your return over the last 1 years would have been 6.15%, for an annualized return of 6.15% (not including any dividends or dividend reinvestments).

How much is Phoenix Biotech Acquisition's stock price per share?

(NASDAQ: PBAX) Phoenix Biotech Acquisition stock price per share is $10.70 today (as of Mar 17, 2023).

What is Phoenix Biotech Acquisition's Market Cap?

(NASDAQ: PBAX) Phoenix Biotech Acquisition's market cap is $245.90M, as of Mar 20, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Phoenix Biotech Acquisition's market cap is calculated by multiplying PBAX's current stock price of $10.70 by PBAX's total outstanding shares of 22,981,250.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.